Browsing eNauka

Browsing by Author Loibl Sibylle

Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)TypeМp-cat.
2023Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trialHolmes Frankie A; Moy Beverly; Delaloge Suzette; Chia Stephen KL; Ejlertsen Bent; Mansi Janine; Iwata Hiroji; Gnant Michael; Buyse Marc; Barrios Carlos H;
Silovski Tajana; Šeparović Robert; Bashford Anna; Zotano Guerrero Angel; Dendeluri Neelima; Patt Debra; Gokmen Erhan; Gore Ira; Smith II John W; Loibl Sibylle; Masuda Norikazu; Tomašević Zorica  ; Petrakova Katarina; DiPrimeo Daniel; Wong Alvin; Martin Miguel; Chan Arlene; ExteNET Study Group;
Article
21aM21a
2020Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2–positive breast cancerConte PierFranco; Schneeweiss Andreas; Loibl Sibylle; Mamounas Eleftherios; von Minckwitz Gunter; Mano Max S; Untch Michael; Huang Chiun-Sheng; Wolmark Norman; Rastogi Priya;
D'Hondt Veronique; Redondo Andres; Stamatović Ljiljana; Bonnefoi Hervé; Castro-Salguero Hugo; Fischer Hans H; Wahl Tanya; Song Chunyan; Boulet Thomas; Trask Peter; Geyer Charles E Jr.;
Article
21aM21a